Pyxis Oncology
(NASDAQ) PYXS
Pyxis Oncology Financials at a Glance
Market Cap
$84.68M
Revenue (TTM)
$13.86M
Net Income (TTM)
$79.62M
EPS (TTM)
$-1.28
P/E Ratio
-1.06
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.37
Volume
6,496
Open
$1.45
Price
$1.37
Volume
6,496
Open
$1.45
Previous Close
$1.37
Daily Range
$1.35 - $1.45
52-Week Range
$0.83 - $5.55
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.37
Volume
6,496
Open
$1.45
Previous Close
$1.37
Daily Range
$1.35 - $1.45
52-Week Range
$0.83 - $5.55
PYXS News
PYXS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pyxis Oncology
Industry
Biotechnology
Sector
Health CareEmployees
56
CEO
Lara S. Sullivan, MD, MBA
Website
www.pyxisoncology.comHeadquarters
Boston, MA 02140, US
PYXS Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-91%
Return on Capital
-1%
Return on Assets
-87%
Earnings Yield
-94.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$84.68M
Shares Outstanding
62.26M
Volume
6.50K
Short Interest
0.00%
Avg. Volume
804.92K
Financials (TTM)
Gross Profit
$11.47M
Operating Income
$84.42M
EBITDA
$84.42M
Operating Cash Flow
$63.50M
Capital Expenditure
$9.00K
Free Cash Flow
$63.51M
Cash & ST Invst.
$66.86M
Total Debt
$18.67M
Pyxis Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.04M
N/A
Gross Profit
$11.47M
N/A
Gross Margin
1.04%
N/A
Market Cap
$84.68M
N/A
Market Cap/Employee
$1.92M
N/A
Employees
44
N/A
Net Income
$18.11M
+49.1%
EBITDA
$18.30M
+1.4%
Quarterly Fundamentals
Net Cash
$48.18M
-54.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$16.98M
-9.4%
Short Term Debt
$1.69M
+16.7%
Return on Assets
-87.00%
N/A
Return on Invested Capital
-1.20%
N/A
Free Cash Flow
$10.43M
+45.9%
Operating Cash Flow
$10.43M
+45.9%